This review examines the role of trauma in psychiatric morbidity and analogous
psychoneurobiological changes. Trauma is a necessary criterion for Post-Traumatic Stress …

Post-traumatic stress disorder (PTSD) is a debilitating mental illness with limited treatment
options and a high treatment dropout rate. Psychedelics, often in combination with …

Post-traumatic stress disorder (PTSD), characterized by abnormally persistent and
distressing memories, is a chronic debilitating condition in need of new treatment options …

Posttraumatic stress disorder (PTSD) is a debilitating, chronic disorder and efficacy rates of
current PTSD treatments are underwhelming. There is a critical need for innovative …

phosphorloxy-N, N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine
(MDMA), best known for their illegal use as psychedelic drugs, are showing promise as …

This review considers future directions for developing effective drugs for posttraumatic stress
disorder (PTSD). At present, we have embarked upon an empirical approach in which …

Psychiatrists and psychotherapists in the US (1970s to 1985) and Switzerland (1988–1993)
used MDMA legally as a prescription drug, to enhance the effectiveness of psychotherapy …

Both core and secondary symptoms of posttraumatic stress disorder (PTSD) respond to
medication, a valuable part of overall PTSD treatment. Treatment options include …

Posttraumatic stress disorder (PTSD) is a common condition for which existing treatments
are ineffective for many patients. Recent discoveries in the neurobiology of learning and …

Introduction Mental illness has a chronic course of illness with a number of clinical
manifestations. Affected individuals experience significant functional, emotional, cognitive …